National Institutes of Health: Cachexia trials

The registry lists 10 Cachexia studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 3Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsCompletedNCT00028314Not applicable
• Nutrition Intervention in AIDS WastingCompletedNCT00006167Phase 4
• AIDS Wasting in Women: Anabolic Effects of TestosteroneCompletedNCT00006158Phase 2
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected ChildrenCompletedNCT00006064
• Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-WastingCompletedNCT00004664Not applicable
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossCompletedNCT00001079Phase 2
• A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral SupplementsCompletedNCT00001077
• A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight LossCompletedNCT00000925Phase 2
• A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight LossCompletedNCT00000854Phase 1
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1